Delivery Order SPE2DB20D1100-SPE2DB24FA4E7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $4,285.23 firm-fixed-price delivery order contract SPE2DB20D3101|SPE2DB24FQXP2 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563172782 TELMISARTAN-AMLODIPINE 80-10 30S medical products. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to military healthcare...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,021.66 fixed-price contract is for the supply of TELMISARTAN-AMLODIPINE 40-5 MG 30S, a cardiovascular medication. The contract has an ultimate completion date of January 3, 2024 and was awarded on January 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract, valued at up to $3,213.78, is for the delivery of 4564788163 - TELMISARTAN-AMLODIPINE 80-5 MG 30S, a pharmaceutical product. The award is a Delivery Order contract with a Firm Fixed Price pricing type. It has an Ultimate Completion Date of June 4, 2024. This contract is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,475.38, is for the delivery of 4567502770 - TELMISARTAN-AMLODIPINE 80-5 MG 30S, a cardiovascular medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,337.94 firm fixed-price delivery order is for the supply of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a pharmaceutical product. The contract has an ultimate completion date of July 10, 2025 and was awarded on July 9, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug...
- This federal contract award, valued at $35,313.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a pharmaceutical product, with a completion date of February 10, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,401.79, is for the delivery of TELMISARTAN-AMLODIPINE 40-5 MG 30S, a cardiovascular medication, with a period of performance through December 18, 2024. The contract is a firm-fixed-price delivery order contract, and there is no set-aside designation indicated. AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.42, is for the delivery of TELMISARTAN-AMLODIPINE 80-5 MG 30S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,001.23 firm fixed-price contract is for the delivery of TELMISARTAN 40 MG TABLET 30S, a generic cardiovascular medication. The contract has an ultimate completion date of January 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,426.36 firm fixed-price delivery order is for the supply of 4567027950 - TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FA4E7Delivery Order
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,775,064 units of the pharmaceutical product TELMISARTAN-AMLODIPINE 40-5 MG 30S. The contract has a completion date of February 27, 2024 and a potential value of $2,958.74. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which falls under a larger indefinite delivery contract (IDC) it holds with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 2/26/24 |